chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Very itchy/Throughout the night they spread throughout my body; Broke out in warm hives on both my arms/it was down my legs too; Still itch especially at night when I am trying to sleep; Broke out in warm hives on both my arms/it was down my legs too; This is a spontaneous report received from a contactable consumer, the patient. A 58-year-old [non-pregnant] adult female received the first dose of intramuscular BNT162B2 (solution for injection; batch/lot and expiry information not provided) as single dose in the right arm on 31Mar2021 at 14:00 (at 58-years-old) for COVID-19 immunization. Relevant medical history included Diabetes, Asthma, High blood pressure, and cholesterol. Concomitant medications sans indication, posology and therapy dates included losartan; dulaglutide (TRULICITY); metformin; levothyroxine sodium (SYNTHROID); and losartan potassium (COZARIL). Prior to the vaccination the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination and denied receiving any other vaccine within four weeks prior to this vaccination. The patient denied being tested for COVID-19 since receiving the vaccine. The patient also denied any allergies to medications, food or other products. The patient reported that on 01Apr2021 at about 12:00 noon, reported as the next day about mid-day, the patient broke out in warm hives on both my arms. On that same date at about 20:00 it was down her legs too and was very itchy. The patient reported that she called her doctor who told her to take something like diphenhydramine hydrochloride (BENADRYL) and use an anti-itch lotion which helped but not the best. The patient explained that throughout the night they spread throughout her body and by 02Apr2021 (Friday) in the morning (AM) it was everywhere except the face, neck, palms of hands and bottom of the feet. The patient explained that it became intense over the next twenty-four hours or so and by 04Apr2021 (Sunday) the patient had to go to the local medical care facility to see a doctor, whom administered a shot and gave prednisone for four days. The patient stated the hives are not as visible though they still itch especially at night when I am trying to sleep. The outcome of the events broke out in warm hives on both my arms, down her legs too and was very itchy, spread throughout her body and itch especially at night when I am trying to sleep was not recovered.   The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling hot, Pruritus, Sleep disorder, Urticaria
Clinical narrative: Very itchy/Throughout the night they spread throughout my body; Broke out in warm hives on both my arms/it was down my legs too; Still itch especially at night when I am trying to sleep; Broke out in warm hives on both my arms/it was down my legs too; This is a spontaneous report received from a contactable consumer, the patient. A 58-year-old [non-pregnant] adult female received the first dose of intramuscular BNT162B2 (solution for injection; batch/lot and expiry information not provided) as single dose in the right arm on 31Mar2021 at 14:00 (at 58-years-old) for COVID-19 immunization. Relevant medical history included Diabetes, Asthma, High blood pressure, and cholesterol. Concomitant medications sans indication, posology and therapy dates included losartan; dulaglutide (TRULICITY); metformin; levothyroxine sodium (SYNTHROID); and losartan potassium (COZARIL). Prior to the vaccination the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination and denied receiving any other vaccine within four weeks prior to this vaccination. The patient denied being tested for COVID-19 since receiving the vaccine. The patient also denied any allergies to medications, food or other products. The patient reported that on 01Apr2021 at about 12:00 noon, reported as the next day about mid-day, the patient broke out in warm hives on both my arms. On that same date at about 20:00 it was down her legs too and was very itchy. The patient reported that she called her doctor who told her to take something like diphenhydramine hydrochloride (BENADRYL) and use an anti-itch lotion which helped but not the best. The patient explained that throughout the night they spread throughout her body and by 02Apr2021 (Friday) in the morning (AM) it was everywhere except the face, neck, palms of hands and bottom of the feet. The patient explained that it became intense over the next twenty-four hours or so and by 04Apr2021 (Sunday) the patient had to go to the local medical care facility to see a doctor, whom administered a shot and gave prednisone for four days. The patient stated the hives are not as visible though they still itch especially at night when I am trying to sleep. The outcome of the events broke out in warm hives on both my arms, down her legs too and was very itchy, spread throughout her body and itch especially at night when I am trying to sleep was not recovered.   The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Corneal infection, Fatigue, Headache, Herpes zoster, Postmenopausal haemorrhage
Clinical narrative: Shingles of the face with impact to vision on right side. Onset 6/11.; Shingles of the face with impact to vision on right side. Onset 6/11.; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient (not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EWo177), via an unspecified route of administration in left arm on an unspecified date as single for covid-19 immunisation. There was no medical history. The patient had no known allergies. Concomitant medications included vitamin d nos; vitamin b nos for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0161), via an unspecified route of administration in left arm on 24Apr2021 at 01:45 PM (at the age of 51 years old) for covid-19 immunisation. The patient did not receive any other vaccines within four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 11Jun2021 at 15:00 patient experienced shingles of the face with impact to vision on right side. onset 6/11. The events resulted in a visit to doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles of the face with impact to vision on right side. onset 6/11 with medication orally and drops for the eye. The outcome of events was not recovered.  Follow-Up (19Jul2021): Follow-up attempts are completed. No further information is expected.  Follow-up (04Aug2021): Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound abdomen
Clinical narrative: Shingles of the face with impact to vision on right side. Onset 6/11.; Shingles of the face with impact to vision on right side. Onset 6/11.; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient (not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EWo177), via an unspecified route of administration in left arm on an unspecified date as single for covid-19 immunisation. There was no medical history. The patient had no known allergies. Concomitant medications included vitamin d nos; vitamin b nos for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0161), via an unspecified route of administration in left arm on 24Apr2021 at 01:45 PM (at the age of 51 years old) for covid-19 immunisation. The patient did not receive any other vaccines within four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 11Jun2021 at 15:00 patient experienced shingles of the face with impact to vision on right side. onset 6/11. The events resulted in a visit to doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles of the face with impact to vision on right side. onset 6/11 with medication orally and drops for the eye. The outcome of events was not recovered.  Follow-Up (19Jul2021): Follow-up attempts are completed. No further information is expected.  Follow-up (04Aug2021): Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster, Visual impairment
Clinical narrative: Shingles of the face with impact to vision on right side. Onset 6/11.; Shingles of the face with impact to vision on right side. Onset 6/11.; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient (not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EWo177), via an unspecified route of administration in left arm on an unspecified date as single for covid-19 immunisation. There was no medical history. The patient had no known allergies. Concomitant medications included vitamin d nos; vitamin b nos for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0161), via an unspecified route of administration in left arm on 24Apr2021 at 01:45 PM (at the age of 51 years old) for covid-19 immunisation. The patient did not receive any other vaccines within four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 11Jun2021 at 15:00 patient experienced shingles of the face with impact to vision on right side. onset 6/11. The events resulted in a visit to doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles of the face with impact to vision on right side. onset 6/11 with medication orally and drops for the eye. The outcome of events was not recovered.  Follow-Up (19Jul2021): Follow-up attempts are completed. No further information is expected.  Follow-up (04Aug2021): Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia
Clinical narrative: MULTIPLE SCLEROSIS; This spontaneous report received from a patient concerned a 64-year-old female. The patient's height, and weight were not reported. The patient's concurrent conditions included degenerative disc disease, diabetes. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, 1 total, administered on 06-APR-2021 in right arm for prophylactic vaccination. No concomitant medications were reported. In APR-2021, 3 weeks after vaccine, patient reported numbness in right leg in right side of thigh. She had more pronounced pain when walking and hard to stand. Sense of numbness was constant but had not spread to other area, radiates from knee to hip sometimes if standing too long. She had appointment with neurologist, but he did not provide any information/diagnosis, but eliminated possibility of a pinched nerve. It was reported that, she had Multiple Sclerosis (MS) but not had symptoms, only brain lesions at this point. It had been 6 years since MS testing, and all came out negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of multiple sclerosis was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210802929 -Covid-19 vaccine ad26.cov2.S- Multiple Sclerosis. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Multiple sclerosis
Clinical narrative: MULTIPLE SCLEROSIS; This spontaneous report received from a patient concerned a 64-year-old female. The patient's height, and weight were not reported. The patient's concurrent conditions included degenerative disc disease, diabetes. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, 1 total, administered on 06-APR-2021 in right arm for prophylactic vaccination. No concomitant medications were reported. In APR-2021, 3 weeks after vaccine, patient reported numbness in right leg in right side of thigh. She had more pronounced pain when walking and hard to stand. Sense of numbness was constant but had not spread to other area, radiates from knee to hip sometimes if standing too long. She had appointment with neurologist, but he did not provide any information/diagnosis, but eliminated possibility of a pinched nerve. It was reported that, she had Multiple Sclerosis (MS) but not had symptoms, only brain lesions at this point. It had been 6 years since MS testing, and all came out negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of multiple sclerosis was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210802929 -Covid-19 vaccine ad26.cov2.S- Multiple Sclerosis. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Facial paresis, Paresis
Clinical narrative: MUSCLES IN THIGHS AND ARMS ACHE AT TIMES; TINGLING AND MINOR WEAKNESS SPREAD TO MY RIGHT LEG; NUMBNESS IN RIGHT ARM (ALSO HAVE PERIODS OF NUMBNESS ON THE RIGHT SIDE OF MY FACE); TINGLING RIGHT ARM HAD SPREAD TO LEFT ARM AND LEFT LEG ALSO; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821287, expiry: UNKNOWN) dose was not reported, administered on 26-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 28-JUL-2021, the subject experienced tingling right arm had spread to left arm and left leg also. On 28-JUL-2021, the subject experienced numbness in right arm (also have periods of numbness on the right side of my face). On 29-JUL-2021, the subject experienced tingling and minor weakness spread to my right leg. On 30-JUL-2021, the subject experienced muscles in thighs and arms ache at times. On 02-AUG-2021, Laboratory data included: Blood test (NR: not provided) Normal, and MRI (NR: not provided) Normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tingling right arm had spread to left arm and left leg also, muscles in thighs and arms ache at times, tingling and minor weakness spread to my right leg, and numbness in right arm (also have periods of numbness on the right side of my face). This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test normal, Magnetic resonance imaging head normal, Muscular weakness, Paraesthesia, Scan with contrast normal
Clinical narrative: MUSCLES IN THIGHS AND ARMS ACHE AT TIMES; TINGLING AND MINOR WEAKNESS SPREAD TO MY RIGHT LEG; NUMBNESS IN RIGHT ARM (ALSO HAVE PERIODS OF NUMBNESS ON THE RIGHT SIDE OF MY FACE); TINGLING RIGHT ARM HAD SPREAD TO LEFT ARM AND LEFT LEG ALSO; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821287, expiry: UNKNOWN) dose was not reported, administered on 26-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 28-JUL-2021, the subject experienced tingling right arm had spread to left arm and left leg also. On 28-JUL-2021, the subject experienced numbness in right arm (also have periods of numbness on the right side of my face). On 29-JUL-2021, the subject experienced tingling and minor weakness spread to my right leg. On 30-JUL-2021, the subject experienced muscles in thighs and arms ache at times. On 02-AUG-2021, Laboratory data included: Blood test (NR: not provided) Normal, and MRI (NR: not provided) Normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tingling right arm had spread to left arm and left leg also, muscles in thighs and arms ache at times, tingling and minor weakness spread to my right leg, and numbness in right arm (also have periods of numbness on the right side of my face). This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Hypoaesthesia, Magnetic resonance imaging, Muscular weakness, Myalgia
Clinical narrative: MUSCLES IN THIGHS AND ARMS ACHE AT TIMES; TINGLING AND MINOR WEAKNESS SPREAD TO MY RIGHT LEG; NUMBNESS IN RIGHT ARM (ALSO HAVE PERIODS OF NUMBNESS ON THE RIGHT SIDE OF MY FACE); TINGLING RIGHT ARM HAD SPREAD TO LEFT ARM AND LEFT LEG ALSO; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821287, expiry: UNKNOWN) dose was not reported, administered on 26-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 28-JUL-2021, the subject experienced tingling right arm had spread to left arm and left leg also. On 28-JUL-2021, the subject experienced numbness in right arm (also have periods of numbness on the right side of my face). On 29-JUL-2021, the subject experienced tingling and minor weakness spread to my right leg. On 30-JUL-2021, the subject experienced muscles in thighs and arms ache at times. On 02-AUG-2021, Laboratory data included: Blood test (NR: not provided) Normal, and MRI (NR: not provided) Normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tingling right arm had spread to left arm and left leg also, muscles in thighs and arms ache at times, tingling and minor weakness spread to my right leg, and numbness in right arm (also have periods of numbness on the right side of my face). This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: MUSCLES IN THIGHS AND ARMS ACHE AT TIMES; TINGLING AND MINOR WEAKNESS SPREAD TO MY RIGHT LEG; NUMBNESS IN RIGHT ARM (ALSO HAVE PERIODS OF NUMBNESS ON THE RIGHT SIDE OF MY FACE); TINGLING RIGHT ARM HAD SPREAD TO LEFT ARM AND LEFT LEG ALSO; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821287, expiry: UNKNOWN) dose was not reported, administered on 26-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 28-JUL-2021, the subject experienced tingling right arm had spread to left arm and left leg also. On 28-JUL-2021, the subject experienced numbness in right arm (also have periods of numbness on the right side of my face). On 29-JUL-2021, the subject experienced tingling and minor weakness spread to my right leg. On 30-JUL-2021, the subject experienced muscles in thighs and arms ache at times. On 02-AUG-2021, Laboratory data included: Blood test (NR: not provided) Normal, and MRI (NR: not provided) Normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tingling right arm had spread to left arm and left leg also, muscles in thighs and arms ache at times, tingling and minor weakness spread to my right leg, and numbness in right arm (also have periods of numbness on the right side of my face). This report was non-serious.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Pruritus, Rash
Clinical narrative: hives; This is a spontaneous report from a contactable consumer (Patient is the reporter). A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiry Date: Not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. Reason for no lot number: of Pfizer BioNTech COVID 19 vaccine: Reporter unwilling to complete the report. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration as dose 1, single for COVID-19 immunisation and experienced extreme fatigue, rash on his arm, Itching. The patient stated that he experienced hives almost on his stomach and it went down and up on his stomach on an unspecified date. It went away now but patient was just a little worried. Adds he doesn't know if it was a rash or hives; he was unsure of the difference. Investigation Assessment: Not Provided. The outcome of event hives was recovered.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: hives; This is a spontaneous report from a contactable consumer (Patient is the reporter). A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiry Date: Not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. Reason for no lot number: of Pfizer BioNTech COVID 19 vaccine: Reporter unwilling to complete the report. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration as dose 1, single for COVID-19 immunisation and experienced extreme fatigue, rash on his arm, Itching. The patient stated that he experienced hives almost on his stomach and it went down and up on his stomach on an unspecified date. It went away now but patient was just a little worried. Adds he doesn't know if it was a rash or hives; he was unsure of the difference. Investigation Assessment: Not Provided. The outcome of event hives was recovered.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Cardiac stress test, Hiccups, Nausea, Tremor
Clinical narrative: UNCONTROLLABLE HANDSHAKE; FEELING REALLY WEAK; HICCUPS; This spontaneous report received from a patient concerned a 58 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included type ii diabetes mellitus, and high blood pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808902, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 19-APR-2021, the subject experienced hiccups. On MAY-2021, the subject experienced uncontrollable handshake. On MAY-2021, the subject experienced feeling really weak. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from hiccups, uncontrollable handshake, and feeling really weak. This report was non-serious.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Hiccups, Tremor
Clinical narrative: UNCONTROLLABLE HANDSHAKE; FEELING REALLY WEAK; HICCUPS; This spontaneous report received from a patient concerned a 58 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included type ii diabetes mellitus, and high blood pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808902, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 19-APR-2021, the subject experienced hiccups. On MAY-2021, the subject experienced uncontrollable handshake. On MAY-2021, the subject experienced feeling really weak. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from hiccups, uncontrollable handshake, and feeling really weak. This report was non-serious.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Chest pain, Electrocardiogram ST segment elevation, Fatigue, Myalgia, Myocarditis
Clinical narrative: Pt. is a 14 y.o. 3 m.o. male who was recently hospitalized from July 31, 2021 to August 1, 2021 due to development of myocarditis which seem to be temporarily related to receiving the second dose of the Pfizer-Biontech SARS-CoV-2 vaccine on July 28, 2021. The day after he received the vaccine he had a high fever to 103° which spontaneously resolved and the next day he felt fine.  On the morning of Saturday, July 31, 2021 he had onset of chest pain and he presented to the emergency department where he was noted to have ST changes on EKG and an elevated troponin level.  His cardiac echo showed normal cardiac structure and function and he had serial troponin levels checked which were increasing although his symptoms quickly resolved. Since his discharge she has been asymptomatic without chest pain, shortness of breath, heart palpitations or fevers.  His high sensitivity troponin was checked on August 2, 2021 and has peaked out at 391 nanograms/liter.  Because of this his anti-inflammatory regimen was changed from ibuprofen monotherapy to Naprosyn 500 mg by mouth twice a day for 14 days and colchicine with a 1.2 mg 2 times a day load and then 0.6 mg 2 times a day for an additional six days.  He had a repeat echocardiogram this morning which has not been read.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pyrexia, Troponin increased
Clinical narrative: Pt. is a 14 y.o. 3 m.o. male who was recently hospitalized from July 31, 2021 to August 1, 2021 due to development of myocarditis which seem to be temporarily related to receiving the second dose of the Pfizer-Biontech SARS-CoV-2 vaccine on July 28, 2021. The day after he received the vaccine he had a high fever to 103° which spontaneously resolved and the next day he felt fine.  On the morning of Saturday, July 31, 2021 he had onset of chest pain and he presented to the emergency department where he was noted to have ST changes on EKG and an elevated troponin level.  His cardiac echo showed normal cardiac structure and function and he had serial troponin levels checked which were increasing although his symptoms quickly resolved. Since his discharge she has been asymptomatic without chest pain, shortness of breath, heart palpitations or fevers.  His high sensitivity troponin was checked on August 2, 2021 and has peaked out at 391 nanograms/liter.  Because of this his anti-inflammatory regimen was changed from ibuprofen monotherapy to Naprosyn 500 mg by mouth twice a day for 14 days and colchicine with a 1.2 mg 2 times a day load and then 0.6 mg 2 times a day for an additional six days.  He had a repeat echocardiogram this morning which has not been read.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Body temperature increased, Chest pain, Coxsackie virus test, Cytomegalovirus test, Echocardiogram
Clinical narrative: Pt. is a 14 y.o. 3 m.o. male who was recently hospitalized from July 31, 2021 to August 1, 2021 due to development of myocarditis which seem to be temporarily related to receiving the second dose of the Pfizer-Biontech SARS-CoV-2 vaccine on July 28, 2021. The day after he received the vaccine he had a high fever to 103° which spontaneously resolved and the next day he felt fine.  On the morning of Saturday, July 31, 2021 he had onset of chest pain and he presented to the emergency department where he was noted to have ST changes on EKG and an elevated troponin level.  His cardiac echo showed normal cardiac structure and function and he had serial troponin levels checked which were increasing although his symptoms quickly resolved. Since his discharge she has been asymptomatic without chest pain, shortness of breath, heart palpitations or fevers.  His high sensitivity troponin was checked on August 2, 2021 and has peaked out at 391 nanograms/liter.  Because of this his anti-inflammatory regimen was changed from ibuprofen monotherapy to Naprosyn 500 mg by mouth twice a day for 14 days and colchicine with a 1.2 mg 2 times a day load and then 0.6 mg 2 times a day for an additional six days.  He had a repeat echocardiogram this morning which has not been read.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Electrocardiogram ST-T change, Epstein-Barr virus antibody negative, HIV antibody negative, HIV antigen negative, Hepatitis C antibody negative
Clinical narrative: Pt. is a 14 y.o. 3 m.o. male who was recently hospitalized from July 31, 2021 to August 1, 2021 due to development of myocarditis which seem to be temporarily related to receiving the second dose of the Pfizer-Biontech SARS-CoV-2 vaccine on July 28, 2021. The day after he received the vaccine he had a high fever to 103° which spontaneously resolved and the next day he felt fine.  On the morning of Saturday, July 31, 2021 he had onset of chest pain and he presented to the emergency department where he was noted to have ST changes on EKG and an elevated troponin level.  His cardiac echo showed normal cardiac structure and function and he had serial troponin levels checked which were increasing although his symptoms quickly resolved. Since his discharge she has been asymptomatic without chest pain, shortness of breath, heart palpitations or fevers.  His high sensitivity troponin was checked on August 2, 2021 and has peaked out at 391 nanograms/liter.  Because of this his anti-inflammatory regimen was changed from ibuprofen monotherapy to Naprosyn 500 mg by mouth twice a day for 14 days and colchicine with a 1.2 mg 2 times a day load and then 0.6 mg 2 times a day for an additional six days.  He had a repeat echocardiogram this morning which has not been read.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Mycobacterium tuberculosis complex test negative, Myocarditis, Pyrexia, Streptococcus test, Streptococcus test negative
Clinical narrative: Pt. is a 14 y.o. 3 m.o. male who was recently hospitalized from July 31, 2021 to August 1, 2021 due to development of myocarditis which seem to be temporarily related to receiving the second dose of the Pfizer-Biontech SARS-CoV-2 vaccine on July 28, 2021. The day after he received the vaccine he had a high fever to 103° which spontaneously resolved and the next day he felt fine.  On the morning of Saturday, July 31, 2021 he had onset of chest pain and he presented to the emergency department where he was noted to have ST changes on EKG and an elevated troponin level.  His cardiac echo showed normal cardiac structure and function and he had serial troponin levels checked which were increasing although his symptoms quickly resolved. Since his discharge she has been asymptomatic without chest pain, shortness of breath, heart palpitations or fevers.  His high sensitivity troponin was checked on August 2, 2021 and has peaked out at 391 nanograms/liter.  Because of this his anti-inflammatory regimen was changed from ibuprofen monotherapy to Naprosyn 500 mg by mouth twice a day for 14 days and colchicine with a 1.2 mg 2 times a day load and then 0.6 mg 2 times a day for an additional six days.  He had a repeat echocardiogram this morning which has not been read.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Troponin increased
Clinical narrative: Pt. is a 14 y.o. 3 m.o. male who was recently hospitalized from July 31, 2021 to August 1, 2021 due to development of myocarditis which seem to be temporarily related to receiving the second dose of the Pfizer-Biontech SARS-CoV-2 vaccine on July 28, 2021. The day after he received the vaccine he had a high fever to 103° which spontaneously resolved and the next day he felt fine.  On the morning of Saturday, July 31, 2021 he had onset of chest pain and he presented to the emergency department where he was noted to have ST changes on EKG and an elevated troponin level.  His cardiac echo showed normal cardiac structure and function and he had serial troponin levels checked which were increasing although his symptoms quickly resolved. Since his discharge she has been asymptomatic without chest pain, shortness of breath, heart palpitations or fevers.  His high sensitivity troponin was checked on August 2, 2021 and has peaked out at 391 nanograms/liter.  Because of this his anti-inflammatory regimen was changed from ibuprofen monotherapy to Naprosyn 500 mg by mouth twice a day for 14 days and colchicine with a 1.2 mg 2 times a day load and then 0.6 mg 2 times a day for an additional six days.  He had a repeat echocardiogram this morning which has not been read.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cardiac stress test, Chest pain, Echocardiogram, Electrocardiogram, Laboratory test
Clinical narrative: Pt. is a 14 y.o. 3 m.o. male who was recently hospitalized from July 31, 2021 to August 1, 2021 due to development of myocarditis which seem to be temporarily related to receiving the second dose of the Pfizer-Biontech SARS-CoV-2 vaccine on July 28, 2021. The day after he received the vaccine he had a high fever to 103° which spontaneously resolved and the next day he felt fine.  On the morning of Saturday, July 31, 2021 he had onset of chest pain and he presented to the emergency department where he was noted to have ST changes on EKG and an elevated troponin level.  His cardiac echo showed normal cardiac structure and function and he had serial troponin levels checked which were increasing although his symptoms quickly resolved. Since his discharge she has been asymptomatic without chest pain, shortness of breath, heart palpitations or fevers.  His high sensitivity troponin was checked on August 2, 2021 and has peaked out at 391 nanograms/liter.  Because of this his anti-inflammatory regimen was changed from ibuprofen monotherapy to Naprosyn 500 mg by mouth twice a day for 14 days and colchicine with a 1.2 mg 2 times a day load and then 0.6 mg 2 times a day for an additional six days.  He had a repeat echocardiogram this morning which has not been read.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Movement disorder, Myocarditis, Pyrexia, Troponin increased
Clinical narrative: Pt. is a 14 y.o. 3 m.o. male who was recently hospitalized from July 31, 2021 to August 1, 2021 due to development of myocarditis which seem to be temporarily related to receiving the second dose of the Pfizer-Biontech SARS-CoV-2 vaccine on July 28, 2021. The day after he received the vaccine he had a high fever to 103° which spontaneously resolved and the next day he felt fine.  On the morning of Saturday, July 31, 2021 he had onset of chest pain and he presented to the emergency department where he was noted to have ST changes on EKG and an elevated troponin level.  His cardiac echo showed normal cardiac structure and function and he had serial troponin levels checked which were increasing although his symptoms quickly resolved. Since his discharge she has been asymptomatic without chest pain, shortness of breath, heart palpitations or fevers.  His high sensitivity troponin was checked on August 2, 2021 and has peaked out at 391 nanograms/liter.  Because of this his anti-inflammatory regimen was changed from ibuprofen monotherapy to Naprosyn 500 mg by mouth twice a day for 14 days and colchicine with a 1.2 mg 2 times a day load and then 0.6 mg 2 times a day for an additional six days.  He had a repeat echocardiogram this morning which has not been read.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dermatitis contact, Rash, Rash pruritic
Clinical narrative: BROKE OUT RASH ON NECK, AND ALL THE WAY BY THROAT TO ALL UNDER ARM, BREAST, BEHIND LEGS, CREASES OF ARM, AND CREASES OF GROIN AREA; This spontaneous report received from a patient concerned a 7 decade old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the subject experienced broke out rash on neck, and all the way by throat to all under arm, breast, behind legs, creases of arm, and creases of groin area. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from broke out rash on neck, and all the way by throat to all under arm, breast, behind legs, creases of arm, and creases of groin area. This report was non-serious.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: BROKE OUT RASH ON NECK, AND ALL THE WAY BY THROAT TO ALL UNDER ARM, BREAST, BEHIND LEGS, CREASES OF ARM, AND CREASES OF GROIN AREA; This spontaneous report received from a patient concerned a 7 decade old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the subject experienced broke out rash on neck, and all the way by throat to all under arm, breast, behind legs, creases of arm, and creases of groin area. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from broke out rash on neck, and all the way by throat to all under arm, breast, behind legs, creases of arm, and creases of groin area. This report was non-serious.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Brain natriuretic peptide increased, C-reactive protein increased, Cardiac imaging procedure abnormal, Chest pain, Ejection fraction decreased
Clinical narrative: myopericarditis - admitted hospital August 3-5, 2021
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Influenza A virus test negative, Influenza B virus test, Influenza virus test negative, Magnetic resonance imaging heart, Myocarditis
Clinical narrative: myopericarditis - admitted hospital August 3-5, 2021
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myoglobin blood increased, SARS-CoV-2 test negative, Troponin increased
Clinical narrative: myopericarditis - admitted hospital August 3-5, 2021
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging heart, Myocarditis, Troponin increased
Clinical narrative: myopericarditis - admitted hospital August 3-5, 2021
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Confusional state, Fall, Loss of consciousness, Memory impairment
Clinical narrative: Got shot and 5 mins or so after I passed out/ possibly had seizure and the guy who gave me shot was not watching me and my husband . I remember waking up to an EpiPen which made further issues plus the side effects from the shot. I ended up going to hospital and was checked out ok but they only did ekg and asked questions I'm sore. My chest is still hurting , my husband said my daughter had to call 911 not any employee at the pharmacy or store ( pharmacy was inside store) were calling 911 , we I yelled out water help someone no employee was running my husband was screaming help she is dying. My child who is 11 had to call 911 and see all this. I'm sore all over my body, I still have nausea, chills, blurry vision, metal taste in my mouth.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Syncope, Thirst, Tremor
Clinical narrative: Got shot and 5 mins or so after I passed out/ possibly had seizure and the guy who gave me shot was not watching me and my husband . I remember waking up to an EpiPen which made further issues plus the side effects from the shot. I ended up going to hospital and was checked out ok but they only did ekg and asked questions I'm sore. My chest is still hurting , my husband said my daughter had to call 911 not any employee at the pharmacy or store ( pharmacy was inside store) were calling 911 , we I yelled out water help someone no employee was running my husband was screaming help she is dying. My child who is 11 had to call 911 and see all this. I'm sore all over my body, I still have nausea, chills, blurry vision, metal taste in my mouth.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Chills, Dysgeusia, Electrocardiogram, Loss of consciousness
Clinical narrative: Got shot and 5 mins or so after I passed out/ possibly had seizure and the guy who gave me shot was not watching me and my husband . I remember waking up to an EpiPen which made further issues plus the side effects from the shot. I ended up going to hospital and was checked out ok but they only did ekg and asked questions I'm sore. My chest is still hurting , my husband said my daughter had to call 911 not any employee at the pharmacy or store ( pharmacy was inside store) were calling 911 , we I yelled out water help someone no employee was running my husband was screaming help she is dying. My child who is 11 had to call 911 and see all this. I'm sore all over my body, I still have nausea, chills, blurry vision, metal taste in my mouth.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Vision blurred
Clinical narrative: Got shot and 5 mins or so after I passed out/ possibly had seizure and the guy who gave me shot was not watching me and my husband . I remember waking up to an EpiPen which made further issues plus the side effects from the shot. I ended up going to hospital and was checked out ok but they only did ekg and asked questions I'm sore. My chest is still hurting , my husband said my daughter had to call 911 not any employee at the pharmacy or store ( pharmacy was inside store) were calling 911 , we I yelled out water help someone no employee was running my husband was screaming help she is dying. My child who is 11 had to call 911 and see all this. I'm sore all over my body, I still have nausea, chills, blurry vision, metal taste in my mouth.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Hypertension, Paraesthesia
Clinical narrative: PT FELT "TINGLEY" AFTER  ABOUT 20 MINUTES AFTER ADMINISTRATION, CAME BACK TO PHARMACY . I GAVE HER BENADRYL AND MEASURED HER BLOOD PRESSURE. HER BLOOD PRESSURE WAS HIGH AND SHE FELT FLUSHED  SHE FELT BETTER AS SOON AS THE BENADRYL STARTED TAKING EFFECT
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Laboratory test, Muscular weakness
Clinical narrative: Extreme joint pain and muscle weakness beginning at right arm and eventually spreading to left arm and then to both legs. Prescribed Prednisone so that limbs would function. Still seeing medical professionals for cause and treatment.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Fatigue, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: COVID infection - cough, scratchy throat,  fatigue, low grade fever.- resolved
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Throat irritation
Clinical narrative: COVID infection - cough, scratchy throat,  fatigue, low grade fever.- resolved
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Patient began feeling light headed and dizzy after receiving the JnJ vaccine (201A21A) at 1550HRS. The patient was aided to a supine position on the ground by RN. Patient sustained no injuries. Patient declined EMS services. Vitals signs were stable as noted. Patient was AO x 4, no pain, no discomfort noted. Patient waited 30 minutes, vital signs were reassessed and stable as noted. Patient left without any injury or further incident.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Dry mouth, Swollen tongue
Clinical narrative: Extremely dry mouth, tongue swelled up. Close to anaphylactic stage.  Started about 15min after vaccine administered. Continued for 1 hour. Took Anti Histamine . Persisted for 1 hr plus
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray, Computerised tomogram, Deep vein thrombosis, Haemoptysis, Scan with contrast
Clinical narrative: Deep Vein Thrombosis - Clots - Coughing up blood.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Condition aggravated, Cough, Dyspnoea, Pneumonia
Clinical narrative: pt. presented to ED with symptoms, SOB, cough and 85% Room air; pneumonia due to COVID
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: fully vaccinated (moderna, patient misplaced vaccination card); symptom onset 7/30/21
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Orthostatic hypotension, Postural orthostatic tachycardia syndrome
Clinical narrative: Developed pots (postural orthostatic hypotension) a month or so after this vaccine. Diagnosed by cardiologist nearly a year later but had symptoms a month after getting the vaccine. Haven't been the same since.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Dyspnoea, Injection site erythema, Injection site induration
Clinical narrative: Big red patch at injection site hard red itchy I also cant smell or taste n have trouble breathing out of my nostrils they?re clogged or stuffy
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Nasal congestion
Clinical narrative: Big red patch at injection site hard red itchy I also cant smell or taste n have trouble breathing out of my nostrils they?re clogged or stuffy
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Erythema, Induration, Injected limb mobility decreased, Nodule
Clinical narrative: Redness, Swelling, itchy, bruising, hard lump, tender to the touch, Upper arm feels tight when trying to raise up, throbbing. Going on 5 days since getting  vaccine. No signs of improvement, very itchy on day 5. Spoke with local pharmacist for advice. She recommended this website and to  go get  it looked at by a doctor.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Skin tightness, Swelling, Tenderness
Clinical narrative: Redness, Swelling, itchy, bruising, hard lump, tender to the touch, Upper arm feels tight when trying to raise up, throbbing. Going on 5 days since getting  vaccine. No signs of improvement, very itchy on day 5. Spoke with local pharmacist for advice. She recommended this website and to  go get  it looked at by a doctor.
Age: 30.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Dyspnoea, Headache, Pain
Clinical narrative: I also received a tetanus shot.   I had difficulty breathing, shortness of breath, headache, body aches